Teva Exits Japanese Generics With Plan To Sell Local Business

Firm Registers Impairment Charge Of Almost $600m As Unit Is Classified As Held-For-Sale

 
• By David Wallace
  
Yen symbol in front of doorway with red background
Teva is facing an exit from its Japanese generics business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business